Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: Apr 28, 2026, 4:00 PM EDT
2.060
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Acurx Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.26 | 8.72 | 8.53 | 7.34 | 10.78 | |
| Research & Development | 1.83 | 5.4 | 6.04 | 4.75 | 2.03 | |
| Operating Expenses | 8.09 | 14.12 | 14.58 | 12.09 | 12.81 | |
| Operating Income | -8.09 | -14.12 | -14.58 | -12.09 | -12.81 | |
| Interest & Investment Income | 0.13 | 0.02 | - | - | - | |
| EBT Excluding Unusual Items | -7.97 | -14.1 | -14.58 | -12.09 | -12.81 | |
| Other Unusual Items | - | - | - | - | 0.07 | |
| Pretax Income | -7.97 | -14.1 | -14.58 | -12.09 | -12.75 | |
| Net Income | -7.97 | -14.1 | -14.58 | -12.09 | -12.75 | |
| Net Income to Common | -7.97 | -14.1 | -14.58 | -12.09 | -12.75 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 85.46% | 27.56% | 17.15% | 26.72% | 37.88% | |
| EPS (Basic) | -5.32 | -17.45 | -23.01 | -22.36 | -29.87 | |
| EPS (Diluted) | -5.32 | -17.45 | -23.01 | -22.36 | -29.87 | |
| EBIT | -8.09 | -14.12 | -14.58 | -12.09 | -12.81 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.